Cargando…
Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy
Poly-(ADP-ribose) polymerase 1 (PARP1) is commonly known for its vital role in DNA damage response and repair. However, its enzymatic activity has been linked to a plethora of physiological and pathophysiological transactions ranging from cellular proliferation, survival and death. For instance, mal...
Autores principales: | Singh, Naveen, Pay, S. Louise, Bhandare, Snehal B., Arimpur, Udhaya, Motea, Edward A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226473/ https://www.ncbi.nlm.nih.gov/pubmed/32295316 http://dx.doi.org/10.3390/cancers12040972 |
Ejemplares similares
-
Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer
por: Starcher, Colton L., et al.
Publicado: (2020) -
XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition
por: Patidar, Praveen L., et al.
Publicado: (2020) -
PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation
por: Min, Ahrum, et al.
Publicado: (2020) -
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
por: Padella, Antonella, et al.
Publicado: (2022) -
PARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy
por: Abecassis, Irina, et al.
Publicado: (2019)